Clinical Trial Update: Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination chemotherapy with or without gemtuzumab in newly diagnosed acute myeloid leukemia in young patients has completed, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab (gemtuzumab ozogamicin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2015-01-13